ATE345141T1 - Kräutermineralzusammensetzung für refraktäre leukämien und lymphome - Google Patents

Kräutermineralzusammensetzung für refraktäre leukämien und lymphome

Info

Publication number
ATE345141T1
ATE345141T1 AT04254356T AT04254356T ATE345141T1 AT E345141 T1 ATE345141 T1 AT E345141T1 AT 04254356 T AT04254356 T AT 04254356T AT 04254356 T AT04254356 T AT 04254356T AT E345141 T1 ATE345141 T1 AT E345141T1
Authority
AT
Austria
Prior art keywords
lymphomas
leukemia
refractive
mineral composition
mixture
Prior art date
Application number
AT04254356T
Other languages
English (en)
Inventor
Nandkishore Managoli
House Sahajanand
Original Assignee
Sahajanand Biotech Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sahajanand Biotech Private Ltd filed Critical Sahajanand Biotech Private Ltd
Application granted granted Critical
Publication of ATE345141T1 publication Critical patent/ATE345141T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT04254356T 2003-07-21 2004-07-21 Kräutermineralzusammensetzung für refraktäre leukämien und lymphome ATE345141T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0317020.6A GB0317020D0 (en) 2003-07-21 2003-07-21 Herbo-mineral formulation for refractory leukemias and lymphomas

Publications (1)

Publication Number Publication Date
ATE345141T1 true ATE345141T1 (de) 2006-12-15

Family

ID=27772368

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04254356T ATE345141T1 (de) 2003-07-21 2004-07-21 Kräutermineralzusammensetzung für refraktäre leukämien und lymphome

Country Status (5)

Country Link
US (1) US20050058722A1 (de)
EP (1) EP1500398B1 (de)
AT (1) ATE345141T1 (de)
DE (1) DE602004003176T2 (de)
GB (2) GB0317020D0 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7736677B2 (en) * 2001-06-20 2010-06-15 Metaproteomics, Llc Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatment
JP5016200B2 (ja) * 2005-04-28 2012-09-05 株式会社ｍｉｍｏｚａｘ アカシア属樹皮由来物を含有する腫瘍の予防及び／又は治療用組成物
WO2007149503A2 (en) * 2006-06-20 2007-12-27 Metaproteomics, Llc. Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatment
EP2052732A4 (de) * 2006-08-10 2012-03-21 Mimozax Co Ltd Antioxidans-zusammensetzung mit einem bestandteil aus der rinde des baums des genus akazie
CN101505777B (zh) * 2006-08-10 2012-05-30 株式会社mimozax 含有来自金合欢属树皮的物质的肿瘤的预防和/或治疗用组合物
WO2008018138A1 (en) * 2006-08-10 2008-02-14 Wood One Co., Ltd. Hypoglycemic composition containing component originating in the bark of tree belonging to the genus acacia
US8673287B2 (en) * 2006-08-10 2014-03-18 Mimozax Co., Ltd. Anti-obesity composition containing acacia bark derivative
CN106038838A (zh) * 2016-03-14 2016-10-26 贵州省中国科学院天然产物化学重点实验室 草药组方提取物在制备治疗白血病药物中的应用
KR20210033947A (ko) * 2018-06-01 2021-03-29 예일 유니버시티 스테로이드 호르몬-관련된 질환 또는 장애를 치료하기 위한 조성물 및 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308838A (en) * 1982-05-07 1994-05-03 Carrington Laboratories, Inc. Uses of aloe products
FR2708198B1 (fr) * 1993-07-28 1995-10-20 Dior Christian Parfums Composition cosmétique ou pharmaceutique, notamment dermatologique contenant un extrait de Tephrosia, en particulier Tephrosia purpurea.
IN179810B (de) * 1996-06-20 1997-12-13 Raptakos Brett & Co Ltd
AU740356B2 (en) * 1997-07-30 2001-11-01 Indena S.P.A. Soya extract, process for its preparation and pharmaceutical composition
KR100239879B1 (ko) * 1997-11-05 2000-02-01 김상조 간암 예방 및 치료용 생약제
BR9814857A (pt) * 1997-11-10 2001-12-26 Sloan Kettering Inst Cancer Processos para tratar leucemia, câncer sólido eleucemia, linfoma ou tumores sólidos em umhumano, e para fabricar uma composiçãofarmacêutica estéril, e, a respectiva composiçãofarmacêutica estéril
US20030099725A1 (en) * 2001-02-26 2003-05-29 Global Cancer Strategies Ltd. Herbal compositions useful as chemopreventive and therapeutic agents and methods of manufacturing same
US20020182274A1 (en) * 2001-03-21 2002-12-05 Kung-Ming Lu Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
GB0116948D0 (en) * 2001-07-11 2001-09-05 Sahajanand Biotech Private Ltd Herbal formulation
GB0116949D0 (en) * 2001-07-11 2001-09-05 Sahajanand Biotech Private Ltd Herbal formulation
US6759061B2 (en) * 2001-08-31 2004-07-06 Renew Life, Inc. Liver function improvement formulation
GB2388539A (en) * 2002-05-15 2003-11-19 Sahajanand Biotech Private Ltd Herbal formulations

Also Published As

Publication number Publication date
GB0416315D0 (en) 2004-08-25
EP1500398A1 (de) 2005-01-26
GB2404586A (en) 2005-02-09
DE602004003176D1 (de) 2006-12-28
US20050058722A1 (en) 2005-03-17
GB0317020D0 (en) 2003-08-27
DE602004003176T2 (de) 2007-09-06
EP1500398B1 (de) 2006-11-15

Similar Documents

Publication Publication Date Title
PT1292594E (pt) Derivados de quinazolina para o tratamento de tumores
ATE355065T1 (de) Therapeutische zusammensetzungen bestehend aus antihypotensiva und antiangiogenika
WO2001066123A3 (en) Composition consisting of phy906 and chemotherapeutic agents
BR0113358A (pt) Derivado de quinazolina ou de um seu sal farmaceuticamente aceitável, processo para a sua preparação, composição farmacêutica, e, uso do derivado ou de um seu sal farmaceuticamente aceitável
BR0115531A (pt) Tratamento de mucosites
WO2002087563A3 (en) Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
ATE345141T1 (de) Kräutermineralzusammensetzung für refraktäre leukämien und lymphome
ATE372764T1 (de) Antipruritische zusammensetzungen und die wundheilung fördernde zusammensetzungen
FI974268A0 (fi) Flavanolignaanien käyttö lääkkeiden, joilla on lisääntymistä torjuvaa vaikutusta kohdussa, munasarjoissa ja rintarauhasessa, valmistamiseksi
DE60118547D1 (de) Pharmazeutische zusammensetzung zur behandlung von kolorektalem krebs welche thalidomid und irinotecan enthält
IL170120A (en) 4,2,1 - Triazines, their use in the preparation of HIV treatment or prophylaxis drugs, containing pharmaceutical preparations and methods for their preparation
BRPI0407234A (pt) Heterociclos substituìdos
WO2003053960A3 (en) Quinline derivates and their use as mek inhibitors
TW200628473A (en) Novel heterocycles
DE60327323D1 (de) Chinazoline derivative und ihre anwendung in der krebsbehandlung
WO2004007557A3 (en) Tf antagonist
CY1106552T1 (el) Ενωσεις ισοχρωμανιου για την θεραπεια ανωμαλιων του κνς
ATE353231T1 (de) Pharmazeutische zusammensetzungen
MXPA04001912A (es) Aminobenzofenonas novedosas.
WO2007056301A3 (en) Antibody therapy for treatment of diseases associated with gluten intolerance
ATE399543T1 (de) Neue synergistische zusammensetzung enthaltend roflumilast und formoterol
BR112022000417A2 (pt) Proteínas de toxina de fusão para tratamento de doenças relacionadas a infecções por cmv
ATE454896T1 (de) Heilkräuterzusammensetzung zur behandlung von aids
Ayush et al. A Study on Arsenic and Arsenic-Containing Mineral Medicines Referenced in Ancient Books of Traditional Mongolian Medicine.
ATE277622T1 (de) Arzneimittel enthaltend xenogene oligo- oder/und polyribonukleotide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties